Dr. Agarwal's Eye Hospital Limited
BSE: DRAGARWQ
Prev Close
4442.25
Open Price
4422.25
Volume
97
Today Low / High
4415 / 4473.85
52 WK Low / High
3500 / 7300
Range
4,194 - 4,636
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 4415, reflecting a change of -27.25 (-0.61343%). The expected target range on the BSE is 4,194 - 4,636. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Dr. Agarwal's Eye Hospital Limited Graph
Dr. Agarwal's Eye Hospital Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Dr. Agarwal's Eye Hospital Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 4,415.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 4,415.00 | 4,459.15 | 4,013.24 - 4,905.07 |
| 4,503.30 | 3,602.64 - 5,403.96 | ||
| 4,547.45 | 3,183.22 - 5,911.69 | ||
| Bearish Scenario | 4,415.00 | 4,370.85 | 3,933.77 - 4,807.94 |
| 4,326.70 | 3,461.36 - 5,192.04 | ||
| 4,282.55 | 2,997.79 - 5,567.32 |
Overview of Dr. Agarwal's Eye Hospital Limited
ISIN
INE934C01018
Industry
Medical - Care Facilities
Vol.Avg
1,849
Market Cap
20,750,500,000
Last Dividend
2.5
Official Website
IPO Date
DCF Diff
-86.11
DCF
4,528
Financial Ratios Every Investor Needs
Stock Dividend of DRAGARWQ
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-11-08 | November 08, 24 | 2.5 | 2.5 | 2024-11-08 | 2024-11-28 | |
| 2023-10-31 | October 31, 23 | 2.5 | 2.5 | 2023-10-31 | 2023-11-18 | |
| 2023-09-14 | September 14, 23 | 3 | 3 | 2023-09-14 | 2023-10-20 | |
| 2022-09-06 | September 06, 22 | 3 | 3 | 2022-09-07 | 2022-10-13 | |
| 2019-09-16 | September 16, 19 | 1.5 | 1.5 | 2019-09-17 | 2019-10-24 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 397.15 Cr | 260.66 Cr | 136.49 Cr | 0.3437 | 0.00 Cr | 0.00 Cr | 79.05 Cr | 54.65 Cr | 116.28 | 123.59 Cr | 0.1376 |
| 2024-03-31 | 319.30 Cr | 134.33 Cr | 184.97 Cr | 0.5793 | 0.00 Cr | 52.31 Cr | 66.46 Cr | 46.36 Cr | 98.64 | 95.96 Cr | 0.1452 |
| 2023-03-31 | 267.23 Cr | 60.96 Cr | 206.27 Cr | 0.7719 | 0.00 Cr | 42.24 Cr | 56.22 Cr | 36.92 Cr | 78.55 | 77.62 Cr | 0.1382 |
| 2022-03-31 | 200.96 Cr | 46.64 Cr | 154.32 Cr | 0.7679 | 0.00 Cr | 31.69 Cr | 38.56 Cr | 24.10 Cr | 51.29 | 59.92 Cr | 0.1199 |
| 2021-03-31 | 139.56 Cr | 32.50 Cr | 107.06 Cr | 0.7671 | 0.00 Cr | 24.52 Cr | 12.26 Cr | -1.44 Cr | -3.06 | 31.79 Cr | -0.0103 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 12.17 Cr | 613.32 Cr | 403.71 Cr | 209.6100 Cr | 333.16 Cr | 320.99 Cr | 13.40 Cr | 493.08 Cr | 0.00 Cr | 0.00 Cr | 10.03 Cr | 86.9800 Cr |
| 2024-03-31 | 32.88 Cr | 495.76 Cr | 338.61 Cr | 157.1500 Cr | 268.02 Cr | 235.14 Cr | 10.70 Cr | 416.60 Cr | 1.84 Cr | 0.00 Cr | 1.05 Cr | 80.7700 Cr |
| 2023-03-31 | 27.38 Cr | 389.94 Cr | 276.60 Cr | 113.3400 Cr | 232.47 Cr | 205.09 Cr | 6.00 Cr | 325.04 Cr | 1.08 Cr | 0.00 Cr | 4.28 Cr | 55.0800 Cr |
| 2022-03-31 | 28.11 Cr | 314.01 Cr | 235.84 Cr | 78.1700 Cr | 193.46 Cr | 165.35 Cr | 5.73 Cr | 244.63 Cr | 0.85 Cr | 0.00 Cr | 2.30 Cr | 53.3500 Cr |
| 2021-03-31 | 21.52 Cr | 155.23 Cr | 100.57 Cr | 54.6628 Cr | 67.55 Cr | 46.02 Cr | 5.21 Cr | 95.82 Cr | 1.73 Cr | 0.00 Cr | 5.18 Cr | 48.5997 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 91.3600 Cr | -132.8400 Cr | 19.7600 Cr | -11.5000 Cr | 0.0000 Cr | 12.1700 Cr | -102.8600 Cr | 54.6500 Cr | 45.0500 Cr | -2.3500 Cr | -3.6500 Cr |
| 2024-03-31 | 90.4600 Cr | -70.9600 Cr | -14.0000 Cr | 19.1400 Cr | 5.5000 Cr | 32.8800 Cr | -71.3200 Cr | 46.3600 Cr | 7.4700 Cr | -2.5800 Cr | -3.7500 Cr |
| 2023-03-31 | 69.6200 Cr | -70.6100 Cr | 0.2600 Cr | -1.2200 Cr | -0.7300 Cr | 27.3800 Cr | -70.8400 Cr | 36.9200 Cr | 11.8900 Cr | -1.4100 Cr | -0.2700 Cr |
| 2022-03-31 | 56.6800 Cr | -46.2800 Cr | -3.8100 Cr | 9.9500 Cr | 6.5900 Cr | 28.1100 Cr | -46.7300 Cr | 24.1000 Cr | 10.3100 Cr | -0.0171 Cr | -0.5100 Cr |
| 2021-03-31 | 33.8734 Cr | -10.9681 Cr | -7.5999 Cr | 22.6910 Cr | 15.3054 Cr | 21.5242 Cr | -11.1824 Cr | -1.4386 Cr | 3.9724 Cr | -0.0358 Cr | 2.7623 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 99.93 Cr | 55.40 Cr | 44.53 Cr | 0.4456 | 44.53 Cr | 15.99 Cr | 34.02 | 31.35 Cr | 0.1600 |
| 2024-12-31 | 95.11 Cr | 42.97 Cr | 52.14 Cr | 0.5482 | 15.60 Cr | 10.40 Cr | 22.13 | 27.93 Cr | 0.1093 |
| 2024-09-30 | 102.19 Cr | 66.69 Cr | 35.50 Cr | 0.3474 | 20.52 Cr | 14.15 Cr | 30.11 | 32.16 Cr | 0.1385 |
| 2024-06-30 | 100.02 Cr | 63.72 Cr | 36.30 Cr | 0.3629 | 21.54 Cr | 14.11 Cr | 30.02 | 31.81 Cr | 0.1411 |
| 2024-03-31 | 80.72 Cr | 51.96 Cr | 28.76 Cr | 0.3563 | 16.91 Cr | 12.79 Cr | 27.21 | 26.90 Cr | 0.1584 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 12.17 Cr | 12.63 Cr | 24.80 Cr | 13.97 Cr | 13.40 Cr | 55.94 Cr | 493.08 Cr | 613.32 Cr | 403.71 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 14.96 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -184.04 Cr |
| 2024-09-30 | 14.15 Cr | 13.49 Cr | 28.45 Cr | 16.25 Cr | 11.80 Cr | 60.95 Cr | 451.29 Cr | 568.83 Cr | 384.79 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 33.74 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -157.15 Cr |
| 2024-03-31 | 33.74 Cr | 2.82 Cr | 33.74 Cr | 13.40 Cr | 9.75 Cr | 59.83 Cr | 412.27 Cr | 495.76 Cr | 338.61 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 10.40 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 14.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 14.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 12.79 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 9.44 Cr | 9.44 Cr | 0.00 Cr | 0.00 Cr | -28.01 Cr | 9.44 Cr | 37.45 Cr | 0.00 Cr | 9.44 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,217.50 | ₹1,183,588,972,500.00 | ₹444,022.00 |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,309.50 | ₹1,050,996,457,500.00 | ₹27,517.00 |
| Fortis Healthcare Limited | FORTIS | ₹801.10 | ₹604,796,853,800.00 | ₹352,850.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,954.00 | ₹399,321,394,000.00 | ₹57,849.00 |
| Global Health Limited | MEDANTA | ₹1,317.50 | ₹353,863,859,975.00 | ₹29,518.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹588.60 | ₹304,966,020,600.00 | ₹309,692.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹752.00 | ₹300,904,528,000.00 | ₹209,062.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,509.00 | ₹153,241,476,066.00 | ₹46,904.00 |
| HealthCare Global Enterprises Limited | HCG | ₹568.75 | ₹79,292,281,250.00 | ₹17,737.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹639.45 | ₹61,613,792,305.00 | ₹335,332.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹482.50 | ₹44,232,222,500.00 | ₹74,215.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹244.00 | ₹33,891,600,000.00 | ₹15,350.00 |
Key Executives
Gender: female
Year Born:
Gender: male
Year Born: 1986
Gender: Not Specified
Year Born: 1960
Gender: Not Specified
Year Born: 1983
Gender: male
Year Born:
Gender: Not Specified
Year Born: 1955
Gender: Not Specified
Year Born: 1977
Gender: female
Year Born:
FAQs about Dr. Agarwal's Eye Hospital Limited
The CEO is Adil Agarwal M.B.B.S, M.S, MBA.
The current price is ₹4,415.00.
The range is ₹3500-7300.
The market capitalization is ₹2,075.05 crores.
The dividend yield is 0.06%.
The P/E ratio is 37.97.
The company operates in the Healthcare sector.
Overview of Dr. Agarwal's Eye Hospital Limited (ISIN: INE934C01018) is a leading Medical - Care Facilities in India. With a market capitalization of ₹2,075.05 crores and an average daily volume of 1,849 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹2.5.